Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults

Celeste Porsbjerg; Charlotte Ulrik; Tina Skjold; Vibeke Backer; Birger Laerum; Sverre Lehman; Crister Janson; Thomas Sandstrøm; Leif Bjermer; Barbro Dahlen; Bo Lundbäck; Dora Ludviksdottir; Unnur Björnsdóttir; Alan Altraja; Lauri Lehtimäki; Paula Kauppi; Jussi Karjalainen; Hannu Kankaanranta

doi:10.1080/20018525.2018.1440868

Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults

Celeste Porsbjerg, Charlotte Ulrik, Tina Skjold, Vibeke Backer, Birger Laerum, Sverre Lehman, Crister Janson, Thomas Sandstrøm, Leif Bjermer, Barbro Dahlen, Bo Lundbäck, Dora Ludviksdottir, Unnur Björnsdóttir, Alan Altraja, Lauri Lehtimäki, Paula Kauppi, Jussi Karjalainen, Hannu Kankaanranta

Department of Clinical Medicine

16 Citations (Scopus)

39 Downloads (Pure)

Abstract

Although a minority of asthma patients suffer from severe asthma, they represent a major clinical challenge in terms of poor symptom control despite high-dose treatment, risk of exacerbations, and side effects. Novel biological treatments may benefit patients with severe asthma, but are expensive, and are only effective in appropriately targeted patients. In some patients, symptoms are driven by other factors than asthma, and all patients with suspected severe asthma ('difficult asthma') should undergo systematic assessment, in order to differentiate between true severe asthma, and 'difficult-to-treat' patients, in whom poor control is related to factors such as poor adherence or co-morbidities. The Nordic Consensus Statement on severe asthma was developed by the Nordic Severe Asthma Network, consisting of members from Norway, Sweden, Finland, Denmark, Iceland and Estonia, including representatives from the respective national respiratory scientific societies with the aim to provide an overview and recommendations regarding the diagnosis, systematic assessment and management of severe asthma. Furthermore, the Consensus Statement proposes recommendations for the organization of severe asthma management in primary, secondary, and tertiary care.

Original language	English
Article number	1440868
Journal	European Clinical Respiratory Journal
Volume	5
Issue number	1
ISSN	2001-8525
DOIs	https://doi.org/10.1080/20018525.2018.1440868
Publication status	Published - 1 Jan 2018

Access to Document

10.1080/20018525.2018.1440868Licence: CC BY

Nordic consensus statement on the systematic assessment and management of possible severe asthma in adultsFinal published version, 2.15 MBLicence: CC BY

Cite this

Porsbjerg, C., Ulrik, C., Skjold, T., Backer, V., Laerum, B., Lehman, S., Janson, C., Sandstrøm, T., Bjermer, L., Dahlen, B., Lundbäck, B., Ludviksdottir, D., Björnsdóttir, U., Altraja, A., Lehtimäki, L., Kauppi, P., Karjalainen, J., & Kankaanranta, H. (2018). Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults. European Clinical Respiratory Journal, 5(1), Article 1440868. https://doi.org/10.1080/20018525.2018.1440868

Porsbjerg, C , Ulrik, C, Skjold, T, Backer, V, Laerum, B, Lehman, S, Janson, C, Sandstrøm, T, Bjermer, L, Dahlen, B, Lundbäck, B, Ludviksdottir, D, Björnsdóttir, U, Altraja, A, Lehtimäki, L, Kauppi, P, Karjalainen, J & Kankaanranta, H 2018, 'Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults', European Clinical Respiratory Journal, vol. 5, no. 1, 1440868. https://doi.org/10.1080/20018525.2018.1440868

@article{4dcc2aa87df44dbfb8361761564c074b,

title = "Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults",

abstract = "Although a minority of asthma patients suffer from severe asthma, they represent a major clinical challenge in terms of poor symptom control despite high-dose treatment, risk of exacerbations, and side effects. Novel biological treatments may benefit patients with severe asthma, but are expensive, and are only effective in appropriately targeted patients. In some patients, symptoms are driven by other factors than asthma, and all patients with suspected severe asthma ('difficult asthma') should undergo systematic assessment, in order to differentiate between true severe asthma, and 'difficult-to-treat' patients, in whom poor control is related to factors such as poor adherence or co-morbidities. The Nordic Consensus Statement on severe asthma was developed by the Nordic Severe Asthma Network, consisting of members from Norway, Sweden, Finland, Denmark, Iceland and Estonia, including representatives from the respective national respiratory scientific societies with the aim to provide an overview and recommendations regarding the diagnosis, systematic assessment and management of severe asthma. Furthermore, the Consensus Statement proposes recommendations for the organization of severe asthma management in primary, secondary, and tertiary care.",

author = "Celeste Porsbjerg and Charlotte Ulrik and Tina Skjold and Vibeke Backer and Birger Laerum and Sverre Lehman and Crister Janson and Thomas Sandstr{\o}m and Leif Bjermer and Barbro Dahlen and Bo Lundb{\"a}ck and Dora Ludviksdottir and Unnur Bj{\"o}rnsd{\'o}ttir and Alan Altraja and Lauri Lehtim{\"a}ki and Paula Kauppi and Jussi Karjalainen and Hannu Kankaanranta",

year = "2018",

month = jan,

day = "1",

doi = "10.1080/20018525.2018.1440868",

language = "English",

volume = "5",

journal = "European Clinical Respiratory Journal",

issn = "2001-8525",

publisher = "Co-Action Publishing",

number = "1",

}

TY - JOUR

T1 - Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults

AU - Porsbjerg, Celeste

AU - Ulrik, Charlotte

AU - Skjold, Tina

AU - Backer, Vibeke

AU - Laerum, Birger

AU - Lehman, Sverre

AU - Janson, Crister

AU - Sandstrøm, Thomas

AU - Bjermer, Leif

AU - Dahlen, Barbro

AU - Lundbäck, Bo

AU - Ludviksdottir, Dora

AU - Björnsdóttir, Unnur

AU - Altraja, Alan

AU - Lehtimäki, Lauri

AU - Kauppi, Paula

AU - Karjalainen, Jussi

AU - Kankaanranta, Hannu

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Although a minority of asthma patients suffer from severe asthma, they represent a major clinical challenge in terms of poor symptom control despite high-dose treatment, risk of exacerbations, and side effects. Novel biological treatments may benefit patients with severe asthma, but are expensive, and are only effective in appropriately targeted patients. In some patients, symptoms are driven by other factors than asthma, and all patients with suspected severe asthma ('difficult asthma') should undergo systematic assessment, in order to differentiate between true severe asthma, and 'difficult-to-treat' patients, in whom poor control is related to factors such as poor adherence or co-morbidities. The Nordic Consensus Statement on severe asthma was developed by the Nordic Severe Asthma Network, consisting of members from Norway, Sweden, Finland, Denmark, Iceland and Estonia, including representatives from the respective national respiratory scientific societies with the aim to provide an overview and recommendations regarding the diagnosis, systematic assessment and management of severe asthma. Furthermore, the Consensus Statement proposes recommendations for the organization of severe asthma management in primary, secondary, and tertiary care.

AB - Although a minority of asthma patients suffer from severe asthma, they represent a major clinical challenge in terms of poor symptom control despite high-dose treatment, risk of exacerbations, and side effects. Novel biological treatments may benefit patients with severe asthma, but are expensive, and are only effective in appropriately targeted patients. In some patients, symptoms are driven by other factors than asthma, and all patients with suspected severe asthma ('difficult asthma') should undergo systematic assessment, in order to differentiate between true severe asthma, and 'difficult-to-treat' patients, in whom poor control is related to factors such as poor adherence or co-morbidities. The Nordic Consensus Statement on severe asthma was developed by the Nordic Severe Asthma Network, consisting of members from Norway, Sweden, Finland, Denmark, Iceland and Estonia, including representatives from the respective national respiratory scientific societies with the aim to provide an overview and recommendations regarding the diagnosis, systematic assessment and management of severe asthma. Furthermore, the Consensus Statement proposes recommendations for the organization of severe asthma management in primary, secondary, and tertiary care.

U2 - 10.1080/20018525.2018.1440868

DO - 10.1080/20018525.2018.1440868

M3 - Review

C2 - 29535852

SN - 2001-8525

VL - 5

JO - European Clinical Respiratory Journal

JF - European Clinical Respiratory Journal

IS - 1

M1 - 1440868

ER -

Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults

Abstract

Access to Document

Fingerprint

Cite this